Pharmacotherapy for social anxiety disorder: an update.
Article Details
- CitationCopy to clipboard
Van Ameringen M, Mancini C, Patterson B, Simpson W
Pharmacotherapy for social anxiety disorder: an update.
Isr J Psychiatry Relat Sci. 2009;46(1):53-61.
- PubMed ID
- 19728573 [ View in PubMed]
- Abstract
Since the emergence of social phobia into the diagnostic nomenclature, we have seen an exponential expansion in our knowledge regarding effective treatment of this disorder. The literature clearly supports the use of SSRIs and the SNRI venlafaxine ER as first line pharmacological agents in the treatment of GSAD. In this article, treatment studies of pharmacotherapy of social phobia are summarized. Additional issues such as comparative efficacy, treatment resistance and relapse-prevention are reviewed.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Venlafaxine Sodium-dependent noradrenaline transporter Protein Humans YesInhibitorDetails Venlafaxine Sodium-dependent serotonin transporter Protein Humans YesInhibitorDetails